ReproLegal Helpline

Amid pending court cases and ballot initiatives, journalistic coverage of medication abortion has never been more crucial. This piece aims to help inform the narrative with scientific evidence.

by Naseem S. Miller
November 1, 2023

Access to mifepristone, a medication that’s used for the safe termination of early pregnancy, hangs in the balance while the U.S. Supreme Court decides whether to take up a case that could determine the legal future of the abortion medication.

In August, the 5th U.S. Circuit Court of Appeals ruled that mifepristone should not be prescribed past the seventh week of pregnancy, prescribed via telemedicine, or shipped to patients through the mail. In September, the Justice Department asked the Supreme Court to consider a challenge to that ruling.

Continued: https://journalistsresource.org/health/mifepristone-research-roundup/

Latin
American groups are sharing their abortion access models with US activists in
as Roe v Wade stands to be overturned

Cecilia Nowell
Fri 10 Jun 2022

In late January, nearly 70 abortion rights activists from across Mexico
gathered in a city along the US-Mexico border. For three days, they huddled in
hotel conference rooms, video chatting with activists in the US, who had been
unable to travel due to Covid-19 and an Arctic cold front. Together, they
strategized how to support Americans as abortion restrictions proliferated
across the US.

“It was three days of very, very, very, very cold outside, but very, very warm
inside,” Verónica Cruz Sánchez, director of Las Libres, a feminist organization
based in Guanajuato, Mexico, said.

Continued: https://www.theguardian.com/world/2022/jun/10/mexico-abortion-access-americans

Abortion pill mifepristone: An explainer and research roundup about its history, safety and future

How Mexican feminists are helping Americans get abortions